Effect of Omega-3 polyunsaturated fatty acids in patients with heart failure and preserved ejection fraction

Effect of Omega-3 polyunsaturated fatty acids in patients with heart failure and preserved ejection fraction - Effect of Omega-3 polyunsaturated fatty acids in patients with heart failure and preserved ejection fraction

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012603

Enrollment

Registered

2013-12-16

Start date

2013-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure and preserved ejection fraction

Interventions

1800mg of EPA daily with 6 months of follow up control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: symptomatic out patients had a EF more than 50% and E/e' more than 15 or(8<E/e'<15 and BNP>200) and hyperlipemia

Exclusion criteria

Exclusion criteria: reduced LVEF accute coronary syndromes severe valvular heart disease neoplasms

Design outcomes

Primary

Measure	Time frame
diastolic function (E/e')on echocardiography cardiac function on MRI	—

Countries

Japan

Contacts

Public ContactHidekuni Kirigaya

Kanagawa Cardiovascular and Respiratory Center cardiovascular medicine

ycum_51st_syougai@yahoo.co.jp045(701)9581

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026